ABIONYX Pharma SA
EPA:ABNX.PA
1.26 (EUR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 2.512 | 1.256 | 2.128 | 1.064 | 2.622 | 1.311 | 2.63 | 1.315 | 0.648 | 0.324 | 0.027 | 0.014 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.087 | 0.087 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 1.341 | 0.942 | 2.158 | 1.07 | 2.174 | 1.039 | 2.576 | 1.269 | 0.485 | 0.208 | 0.038 | 0 | 0.042 | 0 | 0.038 | 0 | 0.036 | 0 | 0.036 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 1.171 | 0.315 | -0.03 | -0.006 | 0.448 | 0.272 | 0.054 | 0.046 | 0.163 | 0.116 | -0.011 | 0.014 | -0.042 | 0 | -0.038 | 0 | -0.036 | 0 | -0.036 | 0 | 0.087 | 0.087 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0.466 | 0.25 | -0.014 | -0.005 | 0.171 | 0.207 | 0.021 | 0.035 | 0.252 | 0.358 | -0.407 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 1.453 | 1.072 | 1.449 | 0.38 | 1.143 | 0.93 | 1.42 | 0.352 | 3.24 | 1.824 | 2.437 | 1.015 | 1.749 | 0.875 | 0.566 | 0.283 | 0.612 | 0.306 | 0.705 | 0.353 | 1.621 | 1.621 | 1.131 | 1.131 | 1.762 | 1.762 | 1.394 | 1.394 | 4.441 | 4.441 | 6.001 | 6.001 | 4.475 | 4.475 | 2.912 | 2.912 | 0.943 | 0.943 | 1.194 | 1.194 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 1.687 | 0.573 | 1.445 | 0.732 | 1.709 | 0.903 | 1.818 | 0.928 | 1.683 | 0.876 | 0.546 | 0.292 | 0.599 | 0.321 | 0.591 | 0.315 | 0.624 | 0.33 | 1.085 | 0.561 | 0.45 | 0.45 | 0.658 | 0.658 | 0.491 | 0.491 | 0.378 | 0.378 | 1.602 | 1.602 | 1.914 | 1.914 | 0.925 | 0.925 | 0.532 | 0.532 | 0.907 | 0.907 | 0.579 | 0.579 |
Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Expenses
| 3.14 | 0.972 | 2.894 | 1.117 | 2.852 | 1.075 | 3.238 | 1.319 | 4.923 | 1.752 | 2.983 | 1.287 | 2.348 | 0.486 | 1.157 | 0.485 | 1.236 | 0.541 | 1.79 | 1.559 | 1.887 | 1.887 | 1.456 | 1.456 | 2.18 | 2.18 | 0.393 | 0.393 | 4.937 | 4.937 | 7.094 | 7.094 | 4.598 | 4.598 | 3.317 | 3.317 | 1.348 | 1.348 | 1.612 | 1.612 |
Operating Income
| -1.969 | -0.592 | -2.924 | -1.114 | -2.404 | -0.827 | -3.184 | -1.228 | -4.76 | -1.683 | -2.994 | -1.293 | -2.39 | -0.964 | -1.195 | -0.52 | -1.272 | -0.54 | -1.826 | -0.723 | -1.393 | -1.393 | -1.492 | -1.492 | -1.874 | -1.874 | -1.445 | -1.445 | -4.997 | -4.997 | -7.021 | -7.021 | -4.586 | -4.586 | -3.152 | -3.152 | -1.432 | -1.432 | -1.603 | -1.603 |
Operating Income Ratio
| -0.784 | -0.471 | -1.374 | -1.047 | -0.917 | -0.631 | -1.211 | -0.933 | -7.346 | -5.194 | -110.889 | -95.778 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.006 | -16.006 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 0.005 | -0.043 | -0.014 | -0.01 | 0.008 | -0.001 | -0.082 | -0.048 | 0.053 | 0.045 | 0.04 | 0.02 | 0.961 | 0.481 | 0.121 | 0.06 | -0.167 | -0.084 | 4.579 | 2.29 | -0.055 | -0.055 | -0.213 | -0.213 | -0.262 | -0.262 | 1.093 | 1.093 | -0.108 | -0.108 | -0.313 | -0.313 | -0.203 | -0.203 | -0.38 | -0.38 | -0.04 | -0.04 | -0.226 | -0.226 |
Income Before Tax
| -1.964 | -0.635 | -2.938 | -1.124 | -2.396 | -0.828 | -3.266 | -1.275 | -4.707 | -1.638 | -2.954 | -1.273 | -1.429 | -0.483 | -1.074 | -0.46 | -1.439 | -0.623 | 2.753 | 1.567 | -1.447 | -1.447 | -1.705 | -1.705 | -2.136 | -2.136 | -0.352 | -0.352 | -5.105 | -5.105 | -7.334 | -7.334 | -4.788 | -4.788 | -3.531 | -3.531 | -1.472 | -1.472 | -1.828 | -1.828 |
Income Before Tax Ratio
| -0.782 | -0.506 | -1.381 | -1.056 | -0.914 | -0.632 | -1.242 | -0.97 | -7.264 | -5.056 | -109.407 | -94.296 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.632 | -16.632 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| -0.694 | 0 | -0.69 | 0 | -0.74 | 0 | -0.716 | 0 | -1.431 | 0 | -0.408 | 0 | -0.463 | 0 | -0.154 | 0 | -0.392 | 0.1 | -0.143 | 0.119 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0.001 | 0.001 | 0 | 0 | 0.003 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0.019 | 0.019 |
Net Income
| -1.27 | -0.635 | -2.248 | -1.124 | -1.656 | -0.828 | -2.55 | -1.275 | -3.276 | -1.638 | -2.546 | -1.273 | -0.966 | -0.483 | -0.92 | -0.46 | -1.047 | -0.523 | 2.896 | 1.448 | -1.448 | -1.448 | -1.705 | -1.705 | -2.136 | -2.136 | -0.353 | -0.353 | -5.105 | -5.105 | -7.331 | -7.331 | -4.788 | -4.788 | -3.531 | -3.531 | -1.472 | -1.472 | -1.81 | -1.81 |
Net Income Ratio
| -0.506 | -0.506 | -1.056 | -1.056 | -0.632 | -0.632 | -0.97 | -0.97 | -5.056 | -5.056 | -94.296 | -94.296 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -16.638 | -16.638 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| -0.041 | -0.021 | -0.079 | -0.04 | -0.059 | -0.03 | -0.092 | -0.046 | -0.13 | -0.065 | -0.1 | -0.052 | -0.041 | -0.021 | -0.043 | -0.021 | -0.048 | -0.024 | 0.15 | 0.075 | -0.077 | -0.077 | -0.093 | -0.093 | -0.12 | -0.12 | -0.019 | -0.019 | -0.28 | -0.28 | -0.41 | -0.41 | -0.27 | -0.27 | -0.23 | -0.23 | -0.11 | -0.11 | -0.14 | -0.14 |
EPS Diluted
| -0.041 | -0.021 | -0.079 | -0.04 | -0.059 | -0.03 | -0.092 | -0.046 | -0.13 | -0.065 | -0.1 | -0.052 | -0.041 | -0.021 | -0.043 | -0.021 | -0.048 | -0.024 | 0.15 | 0.073 | -0.077 | -0.077 | -0.093 | -0.093 | -0.12 | -0.12 | -0.019 | -0.019 | -0.28 | -0.28 | -0.41 | -0.41 | -0.27 | -0.27 | -0.23 | -0.23 | -0.11 | -0.11 | -0.14 | -0.14 |
EBITDA
| -2.384 | -0.555 | -2.669 | -1.077 | -2.08 | -0.794 | -2.883 | -1.194 | -4.688 | -1.673 | -2.956 | -1.287 | -2.348 | -0.957 | -1.157 | -0.516 | -1.236 | -0.537 | -1.79 | -0.72 | -1.385 | -1.385 | -1.481 | -1.481 | -1.866 | -1.866 | -1.433 | -1.433 | -4.986 | -4.986 | -7.007 | -7.007 | -4.571 | -4.571 | -3.14 | -3.14 | -1.403 | -1.403 | -1.589 | -1.589 |
EBITDA Ratio
| -0.949 | -0.441 | -1.254 | -1.012 | -0.793 | -0.605 | -1.096 | -0.908 | -7.235 | -5.162 | -109.481 | -95.333 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.914 | -15.914 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |